Principal AP/CP General Surgical Pathologist w/Hematopathology Sign-Out – Greater Dallas, TX Area
AmeriPath is a leading national provider of anatomic pathology, molecular diagnostic and healthcare information services for the detection, diagnosis, evaluation and treatment of cancer and other medical conditions. AmeriPath has over 400 highly trained, board-certified pathologists and Ph.D. level scientists providing services to physicians, hospitals, clinical laboratories, and ambulatory surgery centers across the United States.
AmeriPath North Texas based in Lewisville, TX is seeking a laboratory-based Principal AP/CP General Surgical Pathologist with board certification in Anatomic and Clinical Pathology and Hematopathology to join their team of 19 pathologists. The pathologist will handle an interesting variety of cases including Hematopathology, Women’s Health (GYN) including GYN Cytology, GU, Breast, Head and Neck (ENT) pathology, and a smaller volume of GI biopsies.
Lewisville, TX is located in the heart of the Dallas Fort Worth Metroplex. It offers a good quality of life with excellent schools, scenic parks, world class dining, professional sports teams, entertainment, and easy access to the DFW International Airport.
Please Log In or Register to Upload a Resume and complete the online Application by visiting careers.questdiagnostics.com, clicking “Job Search” and following the prompts. Because of the large number of applicants to job openings, Quest Diagnostics will only contact qualified candidates for interviews.
Alicia.M.Baldon@QuestDiagnostics.com
Executive Medical Recruiting Consultant
68561
Quest Diagnostics honors our service members and encourages veterans to apply.
While we appreciate and value our staffing partners, we do not accept unsolicited resumes from agencies. Quest will not be responsible for paying agency fees for any individual as to whom an agency has sent an unsolicited resume.
Equal Opportunity Employer: Race/Color/Sex/Sexual Orientation/Gender Identity/Religion/National Origin/Disability/Vets or any other legally protected status.
Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company reported 2020 revenues of $9.44 billion.
Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories.
Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients.
Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions.
The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals.
More information is available at www.questdiagnostics.com.
Language Assistance / Non-Discrimination Notice
Asistencia de Idiomas / Aviso de no Discriminación
語言協助 / 不歧視通知
www.QuestDiagnostics.com/home/nondiscrimination
